This article is more than 5 years old. Information may no longer be current.

Stryker announces more eligible patients are enrolled in hip implant settlement program

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Stryker Corporation announced 95% of additional registered eligible patients have enrolled in a Stryker Orthopaedics settlement program.

This was done under a master settlement agreement, which was announced in December 2016, according to a company release.

Stryker Orthopaedics informed the New Jersey Multicounty and Federal Multidistrict litigations of the added enrollment of patients who underwent revision of a Rejuvenate Modular-Neck hip system and/or the ABG II Modular-Neck hip stem before Dec. 19, 2016. This settlement program is an extension of the 2014 settlement program that covered patients who had revision prior to Nov. 3, 2014.

According to the release, most payments under the settlement agreement are expected to be made by the end of 2017.

Reference:

www.stryker.com